Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 7Unknown 3Recruiting 3Terminated 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 31NIH 2OTHER_GOV 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 6Colorectal Neoplasms 4Prostatic Neoplasms 3Pancreatic Neoplasms 3Neoplasms 3Stomach Neoplasms 2Small Cell Lung Carcinoma 2Sarcoma, Kaposi 2Rectal Neoplasms 2Neoplasm Metastasis 2Multiple Myeloma 2Lung Neoplasms 2Inflammatory Bowel Diseases 2Head and Neck Neoplasms 2HIV Infections 2Colonic Neoplasms 2Carcinoma, Renal Cell 2Uterine Cervical Neoplasms 1Urinary Tract Infections 1Triple Negative Breast Neoplasms 1Tongue Neoplasms 1Stomatitis 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumor 1Renal Insufficiency 1Recurrence 1Radiation Injuries 1Prostatic Diseases 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Postoperative Complications 1

Interventions

Duloxetine Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × OTHER_GOV × Depression × Clear all
NCT02443194 2015-12-03

The Effect of Duloxetine on Mood, Quality of Life and Cognitive Functioning in Glioblastoma Patients

Tel-Aviv Sourasky Medical Center

Phase 3 Terminated
50 enrolled
CNS

Depression, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡